Impact of genomic gains of 3p11-p12 on survival of patients with DLBCL. Kaplan-Meier survival estimates of patients with DLBCL with genomic gains of 3p11-p12 in comparison to their stratification into survival quartiles based on the gene-expression-based outcome predictor model alone³  (P = .029). Q indicates quartile.